サンプル依頼リスト カート
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：HbA1c検査の世界市場：動向、技術、成長機会（2025年）
市場調査レポート
商品コード
1664022

HbA1c検査の世界市場：動向、技術、成長機会（2025年）

The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HbA1c検査の世界市場：動向、技術、成長機会（2025年）
出版日: 2025年02月27日
発行: Kalorama Information
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

1990年代以降、HbA1c検査は糖尿病患者の長期的な血糖コントロールのモニタリングにおいて極めて重要であり、診断のためのグルコース検査を補完してきました。最近の調査では、特に空腹時血糖（FBG）検査と組み合わせた場合の、糖尿病スクリーニングと患者モニタリングにおけるHbA1c検査の有用性が強調されています。本レポートでは、ラボベースとポイントオブケアの両方のHbA1c検査機器を網羅し、世界な視点と特定の地域分析を提供しています。

HbA1c検査業界は、償還承認や団体購買組織や政府による価格交渉など、独自の課題に直面しています。技術革新と市場の成功には、継続的な研究開発投資が不可欠です。こうした課題にもかかわらず、HbA1c検査業界は、世界人口の高齢化と新興市場におけるヘルスケア支出の増加から利益を得ています。

表面化学、ナノテクノロジー、分析科学の進歩により、より便利で正確、かつ非侵襲的なHbA1c測定が可能になると予想されます。糖尿病管理のための深い機械学習アルゴリズムとモバイルアプリの統合は、入院を減らし患者の転帰を改善することを約束し、ヘルスケア革新の新時代の到来を告げるものです。

当レポートでは、世界のHbA1c検査市場について調査し、HbA1cの総市場価値、検査用途別、技術別、市場参入企業別のセグメントを掲載しています。詳細な企業プロファイルは競合考察を提供します。市場データは、2024年を基準年としたメーカーレベルの世界市場を反映しています。人口動向、技術革新、世界市場の拡大を背景に、2024年から2029年までの年間平均成長率（CAGR）を予測し、2024年の競合分析と地域別内訳も掲載しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 概要
    • 診断
    • 分類
    • 妊娠
    • その他
    • リスク要因
    • 糖尿病の人口統計
    • 国際統計
    • 米国の有病率
    • 米国の発生率
    • 米国の死亡者数
    • 米国コスト
  • HbA1c

第3章 HbA1c検査、場所別

  • イントロダクション
    • 試験室でのHbA1c検査
    • POCでのHbA1c検査
  • HbA1c検査場所別市場

第4章 HbA1c検査市場、技術プラットフォーム別

  • 概要
    • クロマトグラフィ
    • 高速液体クロマトグラフィ（HPLC）
    • ボロネート親和性
    • 免疫測定
    • 酵素法とマイクロ光学法
    • その他
  • 技術別市場

第5章 HbA1c検査市場の概要と競合

  • 世界のHbA1c市場全体
  • 国別市場分析
  • 北米
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • スペイン
  • アジア太平洋
    • 日本
    • 中国
    • インド
  • ラテンアメリカ
  • その他
  • 競合分析

第6章 HbA1c検査市場の課題と動向

  • WHO必須IVDリスト
  • グリコアルブミン検査
  • 変更の報告
  • PAMAの課題
  • A1cの人種差
  • 遠隔医療
  • LDTアップデート
  • メディケアとHbA1c検査
  • ITとAI
  • 糖尿病と高齢化社会
  • 高齢化の影響
  • ヘルスケアの効率
  • 糖尿病の合併症
  • 規制上の問題
  • 歯科医院でのHbA1c検査

第7章 HbA1c検査市場の企業プロファイル

  • イントロダクション
  • Abbott
  • A. Menarini Diagnostics, S.r.l.
  • ARKRAY, Inc
  • Beckman Coulter/Danaher
  • Bio-Rad
  • DiaSys Diagnostics Systems GmbH
  • Diazyme Laboratories, Inc
  • EKF Diagnostics Holdings Plc
  • HemoCue/Danaher
  • HUMAN Diagnostics
  • OSANG Healthcare Co, Ltd
  • PTS Diagnostics, Inc
  • QuidelOrtho Corporation
  • Roche Diagnostics Corporation
  • Sebia
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers GmbH
  • Tosoh Bioscience, LLC
  • Trinity Biotech
目次
Product Code: 25-070KA

Kalorama Information's "The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025" provides a comprehensive analysis of the global HbA1c testing market, highlighting key trends, technological advancements, and growth opportunities. This report delves into the geographical distribution, demographic influences, and critical market issues shaping the industry. It offers a detailed examination of market values, regional dynamics, and competitive landscapes, with insights into leading providers.

Since the 1990s, HbA1c testing has been pivotal in monitoring long-term glycemic control in diabetics, complementing glucose tests for diagnosis. Recent research underscores the HbA1c test's utility in diabetes screening and patient monitoring, especially when combined with fasting blood glucose (FBG) tests. The report covers both lab-based and point-of-care HbA1c test devices, providing a global perspective with specific regional analyses.

The market summary includes total HbA1c market values, segmented by test usage, technology, and market participation. Detailed company profiles offer competitive insights. The report's data is derived from extensive primary and secondary research, including interviews with over 20 industry experts, healthcare providers, and government officials. Additional insights were gathered from company representatives, ensuring a robust and accurate market overview.

Market data reflects the world market at the manufacturers' level, with 2024 as the base year. Compound annual growth rates (CAGRs) are projected for the 2024-2029 period, supported by demographic trends, technological innovations, and global market expansion. Competitive analysis and regional breakdowns for 2024 are also provided.

The HbA1c testing industry faces unique challenges, including reimbursement approvals and price negotiations by group purchasing organizations and governments. Continuous R&D investments are crucial for innovation and market success. Despite these challenges, the industry benefits from an aging global population and increased healthcare spending in emerging markets. The report highlights the potential for new competitors, investors, and venture capitalists in the HbA1c testing market.

Advancements in surface chemistry, nanotechnology, and analytical sciences are expected to yield more convenient, accurate, and non-invasive HbA1c assays. The integration of deep machine learning algorithms and mobile apps for diabetes management promises to reduce hospitalizations and improve patient outcomes, heralding a new era of healthcare innovation.

Table of Contents

Chapter 1: Executive Summary

  • Introduction
  • Scope and Methodology
  • Market Summary
    • Table 1-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 1-1: Global HbA1c Testing Market, 2024-2029 ($ million)
  • Market Segmentation
  • Issues and Trends Affecting the HbA1c Testing Market
  • Competitive Analysis

Chapter 2: Introduction

  • Overview
    • Diagnosis
    • Type 1
    • Type 2
    • Classification
    • Type 1
    • Type 2
    • Gestational
    • Other
    • Risk Factors
    • Demographics of Diabetes
    • International Statistics
    • US Prevalence
    • US Incidence
    • US Deaths
    • US Cost
  • HbA1c

Chapter 3: HbA1c Testing by Setting

  • Introduction
    • Laboratory-based HbA1c Testing
    • POC HbA1c Testing
  • Market by HbA1c Testing Setting
    • Table 3-1: Global l HbA1c Test Sales Market and Distribution by Setting, 2024-2029 ($ million) estimated [HbA1c Lab and HbA1c POC]
    • Table 3-2: Selected POC Professional HbA1c Products
    • Table 3-3: Selected POC Self-Testing HbA1c Products

Chapter 4: HbA1c Testing Market by Technology Platforms

  • Overview
    • Chromatography
    • High-Performance Liquid Chromatography (HPLC)
    • Boronate Affinity
    • Immunoassay
    • Enzymatic and Micro-optical Methods
    • Others
  • Market by Technology
    • Table 4-1: Global HbA1c Test Sales Market and Distribution by Technology Platform, 2024-2029 ($ million) estimated [Enzymatic/MODM, HPLC, Immunoassay, Others]
    • Figure 4-1: Global HbA1c Test Sales Market by Technology Platform, 2024-2029 ($ million) estimated (Enzymatic/MODM, HPLC, Immunoassay, Others)
    • Figure 4-2: Global HbA1c Test Distribution by Technology Platform, 2024 (%) (Enzymatic/MODM, HPLC, Immunoassay, Others)

Chapter 5: HbA1c Testing Market Summary and Competitive

  • Total Global HbA1c Market
    • Table 5-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 5-1: Global HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Market Analysis by Country
    • Table 5-2: Global HbA1c Testing Market by Region, Revenues and % Market, 2024-2029 ($ million) estimated [Asia Pacific, Europe, Latin America, North America, ROW]
    • Figure 5-2: Global HbA1c Testing Market by Region, 2024-2029 ($ million) estimated (Asia Pacific, Europe, Latin America, North America, ROW)
    • Figure 5-3: Global HbA1c Testing Market Share, by Region, 2024 (%) (Asia Pacific, Europe, Latin America, North America, ROW)
  • North America
    • Table 5-3: North America HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Europe
    • Table 5-4: Europe HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Germany
    • France
    • Italy
    • United Kingdom
    • Spain
      • Figure 5-4: Europe HbA1c Testing Percentage Participation, by Country, 2024 (%) (France, German, Italy, Spain, United Kingdom, Rest of Europe)
  • Asia Pacific
    • Table 5-5: Asia Pacific HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Japan
    • China
    • India
      • Figure 5-5: Asia Pacific HbA1c Testing Percentage Participation, by Country 2024 (%) (Australia, China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America
    • Table 5-6: Latin America HbA1c Testing Market Analysis, 2024-2029 ($ million)
    • Figure 5-6: Latin America HbA1c Testing Percentage Participation, by Country, 2024 (%) (Brazil, Chile, Columbia, Mexico, Rest of Latin America)
  • Rest of World
    • Table 5-7: Rest of World HbA1c Testing Market Analysis, 2024-2029 ($ million)
  • Competitive Analysis
    • Table 5-8: Global HbA1c Testing Market Estimated Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]
    • Figure 5-7: Global HbA1c Testing Market Estimated Revenues, Leading Suppliers, 2024 ($ million) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]
    • Figure 5-8: Global HbA1c Testing Market Share of Leading Suppliers, 2024 (%) [Abbott, Bio-Rad, Danaher (HemoCue and Beckman Coulter), Roche, Siemens Healthineers, Others]

Chapter 6: Issues and Trends in the HbA1c Testing Market

  • WHO Essential IVD List
    • Table 6-1: WHO Model List of Essential In Vitro Diagnostics (EDL)
  • Glycated Albumin Test
  • Reporting Changes
  • The Challenge of PAMA
  • Racial Differences in A1c
  • Telemedicine
  • LDT Update
  • Medicare and HbA1c Testing
  • IT and AI
  • Diabetes and the Aging World
  • Impact of Aging Populations
    • Figure 6-1: Global Population Trends, Total Population vs. Age 65+ Population, 2000-2050
  • Healthcare Efficiency
  • Diabetes Complications
  • Regulatory Issues
    • Table 6-2: Routine Chemistry CLIA Regulations Acceptable Limits (AP) Changes 2025
  • Dental Office HbA1c Testing

Chapter 7: HbA1c Testing Market Company Profiles

  • Introduction
  • Abbott
    • Table 7-1: Abbott Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 7-2: Abbott Revenues, 2020-2024 ($ million)
  • A. Menarini Diagnostics, S.r.l.
    • Table 7-3: A. Menarini Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ARKRAY, Inc
    • Table 7-4: ARKRAY Corporate Summary
    • Company Overview
    • Products
  • Beckman Coulter/Danaher
    • Table 7-5: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
  • Bio-Rad
    • Table 7-6: Bio-Rad Corporate Summary
    • Company Overview
    • Products
    • Financial Performance
      • Table 7-7: Bio-Rad Corporation Revenue, 2020-2024 ($ million)
  • DiaSys Diagnostics Systems GmbH
    • Table 7-8: DiaSys Diagnostics Systems Corporate Summary
    • Company Overview
    • Products
  • Diazyme Laboratories, Inc.
    • Table 7-9: Diazyme Laboratories Corporate Summary
    • Company Overview
    • Products
  • EKF Diagnostics Holdings Plc
    • Table 7-10: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
  • HemoCue/Danaher
    • Table 7-11: HemoCue Corporate Summary
    • Company Overview
    • Products
  • HUMAN Diagnostics.
    • Table 7-12: HUMAN Diagnostics Corporate Summary
    • Company Overview
    • Products
  • OSANG Healthcare Co, Ltd
    • Table 7-13: OSANG Healthcare Corporate Summary
    • Company Overview
    • Products
  • PTS Diagnostics, Inc
    • Table 7-14: PTS Diagnostics Corporate Summary
    • Company Overview
    • Products
  • QuidelOrtho Corporation
    • Table 7-15: QuidelOrtho Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-16: QuidelOrtho Revenues, 2020-2024 ($ million)
  • Roche Diagnostics Corporation
    • Table 7-17: Roche Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-18: Roche Diagnostics, 2020-2024 (CHF millions)
  • Sebia
    • Table 7-19: Sebia Corporate Summary
    • Company Overview
    • Products
  • Sekisui Diagnostics, LLC
    • Table 7-20: Sekisui Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Siemens Healthineers GmbH
    • Table 7-21: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
  • Performance Review
    • Table 7-22: Siemens Healthineers, 2020-2024 (Euro-million)
  • Tosoh Bioscience, LLC
    • Table 7-23: Tosoh Bioscience Corporate Summary
    • Company Overview
    • Products
  • Trinity Biotech
    • Table 7-24: Trinity Biotech Corporate Summary
    • Company Overview
    • Products